Drug intelligence / Profile preview

Children Chai Fang Jie Du Granule

Development stage: Unknown
Lead developer: Guang'anmen Hospital
Modality: Small Molecules
Administration: Oral

Overview

Children Chai Fang Jie Du Granule is a Traditional Chinese Medicine (TCM) formulation developed by Guang'anmen Hospital of the China Academy of Chinese Medical Sciences. It is specifically designed for pediatric use to treat early-stage influenza, particularly cases characterized by the TCM syndrome of "wind-heat invading the lung." The granule is typically evaluated as an adjunctive therapy to standard antiviral treatments like oseltamivir phosphate to improve clinical outcomes and safety in children aged 3 to 16 years. As a TCM product, it is composed of multiple botanical extracts intended to clear heat and detoxify the respiratory system.

Brand names: Children Chai Fang Jie Du Granule
Other names: Xiao'er Chai Fang Jie Du KeliXiao'er Chai Fang Jie Du Granule

Beyond the preview

Go deeper on Children Chai Fang Jie Du Granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Children Chai Fang Jie Du Granule.